Les complications motrices de la dopathérapie chez le malade parkinsonien : sémiologie clinique et modalités d’évaluation

Marsden, 1982, Fluctuations of disability in Parkinson’s disease: clinical aspects, 96 Kempster, 1989, Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson’s disease, J Neurol Neurosurg Psychiatry, 52, 718, 10.1136/jnnp.52.6.718 Melamed, 1986, Episodic unresponsiveness to single doses of L-dopa in parkinsonian fluctuators, Neurology, 36, 100, 10.1212/WNL.36.1.100 Hillen, 1996, Non motor fluctuations in patients with Parkinson’s disease, Neurology, 47, 1180, 10.1212/WNL.47.5.1180 Gunal, 2002, The clinical profile of non motor fluctuations in Parkinson’s disease patients, Can J Neurol Sci, 29, 61, 10.1017/S0317167100001736 Witjas, 2002, Non motor fluctuations in Parkinson’s disease: frequent and disabling, Neurology, 59, 408, 10.1212/WNL.59.3.408 Fernandez, 1992, Hallucinations and parkinsonian motor fluctuations, Behav Neurol, 5, 83, 10.1155/1992/970751 Girotti, 1986, Motor and cognitive performances of Parkinsonian patients in the on and off phases of the disease, J Neurol Neurosurg Psychiatry, 49, 657, 10.1136/jnnp.49.6.657 Riley, 1993, The spectrum of levodopa-related fluctuations in Parkinson’s disease, Neurology, 43, 1459, 10.1212/WNL.43.8.1459 Poewe, 1994, Clinical aspects of motor fluctuations in Parkinson’s disease, Neurology, 44, S6 Muenter, 1977, Patterns of dystonia (‘I-D-I’ and ‘D-I-D’) in response to L-dopa therapy for Parkinson’s disease, Mayo Clin Proc, 52, 163 Fahn, 1987, Unified idiopathic Parkinson’s disease rating scale, 153 Goetz, 1994, Utility of an objective dyskinesia rating scale for Parkinson’s disease: inter- and intrarater reliability assessment, Mov Disord, 9, 390, 10.1002/mds.870090403